Kathleen A. Rickard, Chief Medical Officer at Verona Pharma plc (VRNA), sold 240,000 shares at $4.90 ($1.2M) on 2024-11-25, disclosed to the SEC on 2024-11-26.
Scheduled sale ($1.2M) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| VRNA | SELL | 2025-05-05 | $881K | — | Filing → |
| VRNA | SELL | 2025-05-01 | $618K | — | Filing → |
| VRNA | SELL | 2025-03-13 | $1.3M | — | Filing → |